Education
About Us
Working with TipRanks
Follow Us
Bioharvest Sciences, Inc. (BHST)
:BHST
BHST Stock Chart & Stats
$11.28
--
Market closed
$11.28
--
Day’s Range― - ―
52-Week Range$4.72 - $12.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)96.09K
Market Cap
$120.07M
Enterprise Value$172.84M
Total Cash (Recent Filing)$10.97M
Total Debt (Recent Filing)$19.84M
Price to Earnings (P/E)―
Beta0.64
Next Earnings
Apr 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding22,654,290
10 Day Avg. Volume67,189
30 Day Avg. Volume96,086
Financial Highlights & Ratios
PEG Ratio0.55
Price to Book (P/B)75.25
Price to Sales (P/S)3.97
P/FCF Ratio-10.51
Enterprise Value/Market Cap1.44
Enterprise Value/Revenue5.28
Enterprise Value/Gross Profit8.92
Enterprise Value/Ebitda-37.50
Forecast
1Y Price Target
$13.00Price Target Upside15.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial StrengthThe company's cash and cash equivalents stood at $11.4M with an additional $19.9M in gross proceeds raised, strengthening the balance sheet.
ProfitabilityGross profit for the quarter increased to $5.6M, or 61% of revenue, showing improved profitability.
Revenue GrowthBioHarvest Sciences Inc. reported revenues of $9.1M, up 39% year over year, indicating strong growth.
Bears Say
BioHarvest Sciences News
BHST FAQ
What was Bioharvest Sciences, Inc.’s price range in the past 12 months?
Bioharvest Sciences, Inc. lowest stock price was $4.72 and its highest was $12.80 in the past 12 months.
What is Bioharvest Sciences, Inc.’s market cap?
Bioharvest Sciences, Inc.’s market cap is $120.07M.
When is Bioharvest Sciences, Inc.’s upcoming earnings report date?
Bioharvest Sciences, Inc.’s upcoming earnings report date is Apr 23, 2026 which is in 128 days.
How were Bioharvest Sciences, Inc.’s earnings last quarter?
Bioharvest Sciences, Inc. released its earnings results on Nov 13, 2025. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.115 by -$0.025.
Is Bioharvest Sciences, Inc. overvalued?
According to Wall Street analysts Bioharvest Sciences, Inc.’s price is currently Undervalued.
Does Bioharvest Sciences, Inc. pay dividends?
Bioharvest Sciences, Inc. does not currently pay dividends.
What is Bioharvest Sciences, Inc.’s EPS estimate?
Bioharvest Sciences, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioharvest Sciences, Inc. have?
Bioharvest Sciences, Inc. has 22,654,290 shares outstanding.
What happened to Bioharvest Sciences, Inc.’s price movement after its last earnings report?
Bioharvest Sciences, Inc. reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.115. Following the earnings report the stock price went down -0.959%.
Which hedge fund is a major shareholder of Bioharvest Sciences, Inc.?
Currently, no hedge funds are holding shares in BHST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BioHarvest Sciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.00 (15.25% Upside)
$13.00 (15.25% Upside)
Blogger Sentiment
Neutral
BHST Sentiment 50%
Sector Average 66%
Sector Average 66%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.82%
12-Months-Change
Fundamentals
Return on Equity
-200.22%
Trailing 12-Months
Asset Growth
36.27%
Trailing 12-Months
Company Description
Bioharvest Sciences, Inc.
BioHarvest Sciences (BHST) is a biotechnology company focused on the development and commercialization of innovative plant-based products, primarily in the health and wellness sectors. The company utilizes its proprietary BioHarvest technology to cultivate high-value plant cell cultures that produce bioactive compounds and nutraceuticals. Its core products include specialized compounds for dietary supplements, cosmetics, and functional foods, aimed at improving health outcomes and enhancing consumer wellness.
BHST Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth, particularly in the CDMO segment, and successful capital raising efforts that fortified the company's balance sheet. However, challenges remain with ongoing net losses and increased operating expenses. The sentiment is balanced due to significant achievements and challenges.View all BHST earnings summariesBHST Stock 12 Month Forecast
Average Price Target
$13.00
▲(15.25% Upside)
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---